Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.
about
In vivo imaging of virological synapses.Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse modelImmunity to retroviral infection: the Friend virus modelProtection against establishment of retroviral persistence by vaccination with a live attenuated virus.Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery miceMajor histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant miceKinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in miceRole of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infectionCD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifsClass switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.New concepts in antibody-mediated immunity.APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virusRetroviral immunology: lessons from a mouse model.B lymphocyte activation by coinfection prevents immune control of friend virus infection.Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infectionHumoral immunity in the Friend retrovirus infection model.Antibody-based therapies as anti-infective agents.Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice.Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment
P2860
Q22251074-1C19A580-D2D4-4549-8D55-A7E4499440C1Q27003380-E2894835-377F-4AE4-AE72-D9BA194A4B63Q28243606-B1FC4464-AAB0-44F1-9F8F-BB8078CD38C7Q33646493-48465075-11FD-48C4-831C-6018DA8CF63EQ33650549-EE5358CA-8A93-4204-8A4F-4294B94AFC18Q33783475-D8CAFAF6-B10E-40C0-B7EF-F57EC13D59ABQ33785520-C4B3533B-E3A1-4143-A4A7-1328DE2DA619Q33787180-BC055543-8388-49A3-8F34-B224CCC206D4Q33816934-D36276BA-9536-4295-8269-564652232025Q33820285-27FE6EE5-68C4-407B-A53F-167A3469F644Q33822962-9504C83A-5358-4733-94F4-7702ACB11834Q33835324-1C98B308-89C7-4E9D-A336-8C7EDF379D77Q33911819-7D691B93-4115-4E13-98A6-33233E876B0DQ34355633-5893E08E-BD2A-4C04-9ABB-40BD35057B67Q34991146-45404777-EB8E-4E9B-828F-F241921C0F63Q35872183-6D6A8729-24FC-4EAD-8953-D506D2424B20Q35926507-A7A15479-ECEB-48C2-9ACD-8B83246AB124Q36031782-0AD784BE-C878-473E-A505-912053BEFBACQ36424006-A84EEA10-84B3-44DC-8469-1088BD950B8AQ37003684-10043C51-5F9D-4623-A91A-F1D856602D32Q37128255-CB20862A-40C3-4044-A386-F0EED0548A63Q37452443-06968602-7025-4A7C-A376-2F0B16FD8A4AQ37484850-8A25292F-3B05-4864-A18A-992070CAC122Q37730925-10582237-2B12-44AD-93CD-29AA3A489896Q39216839-07441EAF-B571-481D-BE87-E521776DA48CQ41914024-408D0478-261E-41EA-8DEB-0B887EB3512AQ42732125-AB6A0E50-0DA7-4EE8-A3DF-AC9170478408
P2860
Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@ast
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@en
type
label
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@ast
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@en
prefLabel
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@ast
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@en
P2093
P2860
P356
P1476
Passive immunotherapy for retr ...... ype and T-cell responsiveness.
@en
P2093
Chesebro B
Hasenkrug KJ
P2860
P304
10492-10495
P356
10.1073/PNAS.92.23.10492
P407
P577
1995-11-01T00:00:00Z